Introduction {#sec1-1}
============

Pompe disease (PD), also referred to as acid maltase deficiency (AMD) or glycogen storage disease type II (GSDII), is a rare autosomal recessive neuromuscular disorder caused by a deficiency of the lysosomal enzyme acid alpha-glucosidase (GAA).^[@ref1]^ A shortage of GAA causes a toxic accumulation of glycogen in many tissues, and in particular in smooth, skeletal, and cardiac muscle. The incidence of the syndrome is variable and depends upon ethnicity and geographical area. It is more prevalent among African-Americans (1:14000)^[@ref2]^ and much less on the European continent (1:40000).^[@ref3]^ From the etiological perspective, PD is caused by different mutations of the genes that interact to synthesize GAA, with a consequent lysosomal storage of glycogen. The mutations most studied in the literature are c.525delT,^[@ref4]^ c.2237G \> A,^[@ref5]^ and c.-32-13T \> G.^[@ref6]^ An increasing number of studies have dealt with the role of autophagy in the genesis of PD. Autophagy, or 'self-eating', is an extremely complex lysosomal degradation process controlled by a network of multiple genes. The main function of this mechanism is to eliminate organelles and obsolete protein aggregates in order to protect the cell from the stress of oxidation and/or nutritional deficiency. Changes in this mechanism are linked to various neurodegenerative pathologies involving accumulation, such as PD, and in the generation of some forms of tumors with cellular senescence.^[@ref7]^

PD is classified into two forms according to the age of onset. The infantile form (infantile-onset Pompe disease - IOPD) clinically arises in the first year of life, while the adult form (late-onset Pompe disease - LOPD) appears between 29 and 33 years of age.^[@ref11]^ IOPD in turn is classified into two types depending on organ involvement and degree of myopathy: the classical form (classic IOPD), which usually leads to death due to cardiac arrest within the first year of life, and the non-classical form (non-classic IOPD), which is characterized by cardiomegaly and muscular weakness, with consequent respiratory insufficiency. Patients affected by non-classic IOPD are not faced with death due to cardiac arrest within the first year of life but generally do not survive beyond early childhood due to serious respiratory problems.

PD damages different organ systems in the body. With respect to the respiratory system, patients develop progressive respiratory insufficiency due to weakness of the diaphragm and intercostal muscles. Effects on the musculoskeletal system include insufficiency of the pelvic girdle muscles, insufficiency of the neck flexor muscles, scapulothoracic winging, and decreased strength of the abdominal wall.^[@ref12]^ Scoliosis^[@ref13]^ and decreased bone density^[@ref14]^ are frequently diagnosed in children with PD. The cardiac muscle is frequently affected in all forms of PD and cases of serious arrhythmias or Wolff-Parkinson-White syndromes have been reported in the literature.^[@ref15]^ Recent studies have highlighted cases of pre-symptomatic hyperCKemia.^[@ref16]^ Finally, several studies indicate that congenital molecular alterations in neuromuscular diseases, like PD, promote cognitive dysfunctions.^[@ref17],[@ref18]^

In 2015, early diagnosis of the pediatric forms of PD was included in the Recommended Uniform Screening Panel (RUSP) by the national study commission on rare and hereditary neonatal disorders.^[@ref19]^ In particular, the commission recommended an evaluation of GAA enzyme activity via a dried blood spot (DBS) test. In cases of insufficient or nonexistent activity, an analytical examination should be made of the systems involved in order to identify the genetic and pathological type. The same algorithm can be applied to the late-onset forms. With regard to treatment, until a few years ago PD was only treated via supportive care. A real turning point in the treatment of PD came in 2007, when enzyme replacement therapy (ERT) was approved for patients with infantile forms of PD. In 2010 ERT was also approved for the lateonset form. In ERT, an extract of recombinant human GAA (also partially extracted from animals) is administered intravenously. This enzyme breaks down the accumulation of glycogen, particularly on the cardiac muscle.^[@ref20]^ ERT has led to a clear decrease in short-term mortality and an improvement in respiratory and cardiac disorders in patients with PD.^[@ref20]^ In particular, significant increases have been reported in the time spent by patients without a ventilator, thereby allowing for greater autonomy and the achievement of new motor abilities.^[@ref24],[@ref25]^ Simultaneous with the benefits of managing vital functions in PD, the change in phenotypic expression introduced by ERT has led to the appearance of additional clinical problems related primarily to rehabilitation. The clinical picture of these patients (with either IOPD or LOPD) is characterized by muscular weakness, with the appearance of facial muscle asthenia, ptosis, insufficiency of the hip flexors and ankle dorsiflexors, difficulty walking, posture disorders, and scoliosis.^[@ref13],[@ref26]^

Based on the above, it is clear that the need for a rehabilitative framework for patients with PD represents a gold standard in managing this syndrome. To date, different authors have developed general guidelines for physiotherapy programs for PD. Clinton *et al*.,^[@ref27]^ for example, recommend team management that integrates interventions by cardiologists, pulmonologists, physiatrists, physiotherapists and occupational therapists ([Table 1](#table001){ref-type="table"} shows all the interventions proposed). Despite this, clinical evidence for the rehabilitative management of this syndrome is rare. The scope of the present review is to look for better available EBM regarding rehabilitation in patients with PD in order to establish practical recommendations for clinical conduct.

Materials and Methods {#sec1-2}
=====================

A systematic review of the literature was made using the following databases: Pubmed, Pedro, Cinhal, Cochrane Library, EDS Base Index, and Trip. The databases were accessed in October 2018. The PICO method was used to formulate the clinical query according to the following parameters: ^[@ref28]^

-   Population: PD patients

-   Intervention: physiotherapy

-   Comparison: inactive control groups

-   Outcome: respiratory function improvements, improvements in range of motion/muscular strength

Inclusion criteria and keywords {#sec2-1}
-------------------------------

Articles considered valid for the review addressed randomized controlled trials (RCT) or cohort studies relating to rehabilitation in patients with PD, with no time limit, but with a study sample of at least six subjects. Only articles in English were selected. [Table 2](#table002){ref-type="table"} summarizes the keywords used to perform the search.

Results {#sec1-3}
=======

A total of 1665 results emerged from the search. [Figure 1](#fig001){ref-type="fig"} shows the process to progressively select the articles found. With an initial screening, all results reported multiple times in the database (437 articles) were eliminated. Following this, a secondary screening of the title and abstract was made, resulting in the elimination of (a) article not dealing with the rehabilitation in patients with PD and (b) types of publications different from what was stated in the inclusion criteria (conference proceedings, extracts from textbooks, single expert opinions, animal-based studies). This second screening allowed an additional 1210 results to be eliminated. Therefore, the fulltext version of a total of 18 articles was assessed. These results were divided thus: 4 studies on individual cohorts, 3 case series, 5 case reports, 3 exploratory studies, and 3 literature reviews addressing the diagnostic procedure for PD.

The 4 studies in the first group were therefore admitted to the final phase of the review. From the detailed analysis of these articles, two approaches to rehabilitation in patients with PD were identified: respiratory muscle rehabilitation and physical activity. The main data used in all the studies included are reported in [Table 3](#table003){ref-type="table"}.^[@ref29]^

Re-education of the respiratory muscles {#sec2-2}
---------------------------------------

A total of 3 studies^[@ref29]^ dealt with the management of respiratory muscles in patients with PD. Chest physical therapy was always practiced as an adjuvant therapy to ERT. All the studies examined were single cohorts. The population studied by Jevnikar *et al.*,^[@ref29]^ and Aslan *et al.*,^[@ref31]^ was composed of patients with LOPD, while only the article by Smith^[@ref30]^ regarded a population with IOPD, which was already severely compromised from the respiratory point of view (patients ventilated for multiple hours per day). With regard to the intervention proposed, Jevnikar^[@ref29]^ followed a protocol of inspiratory muscle training against fixed resistance (threshold). In particular, the patient was first studied with spirometry and then coached to perform 45 minutes of daily training: 15 minutes reaching 30% of the maximal inspiratory pressures (MIP) registered and the remaining time in deep breathing. Smith,^[@ref30]^ instead, developed a protocol in which patients with IOPD followed inspiratory training three times per week in preparation for surgery for diaphragm gene therapy. Using modified equipment (Threshold PEP or Accu- PEEP), patients followed 3-4 series of 6-10 active inhalations during which the maximum tolerated volume should be reached while maintaining SpO^[@ref2]^\>92%. Finally, Aslan developed an inspiratory muscle training program with a threshold lasting 8 weeks in which the 8 patients recruited were asked to perform the exercise two times per day.^[@ref31]^ The level of required inspiratory pressure started at 30% of MIP registered with spirometry, increasing by 2 cm H~2~O each week.

With regard to the outcomes recorded, the levels of MIP were used in all studies,^[@ref29]^ while only the study by Smith^[@ref30]^ examined volume, flux, and post-inhalation compensation time with a threshold (at some points excluding the mechanical ventilation in the children studied). In addition, the electromyographic response of the diaphragm after training was evaluated. Lastly, the study by Aslan^[@ref31]^ assessed the values of peak cough flow (PCF), forced vital capacity (FVC), the FVC/forced expiratory volume ratio in 1 second (FEV1), quality of life using the Nottingham Health Profile (NHP), and quality of sleep using the Pittsburgh Sleep Quality Index (PSQI). The follow-up period varied among the different studies: up to 24 months in the trial by Jevnikar,^[@ref29]^ one year in the study by Smith,^[@ref30]^ and 24 weeks in the study by Aslan.^[@ref31]^

Finally, with respect to the results obtained, the study by Jevnikar^[@ref29]^ highlighted a significant increase in MIP values, in agreement with what was demonstrated by Aslan.^[@ref31]^ This data appears to contrast with what emerged from the study by Smith,^[@ref30]^ in which the pressure values did not change after the intervention. However, these values refer to a pediatric population in part already fully dependent on mechanical ventilation. With regard to the indicators of success, Smith^[@ref30]^ found an increase in the compensatory response to threshold at only 180 days, with an increase in maximum voluntary ventilation in subjects and evidence of diaphragm activity on the electromyography. Finally, Aslan^[@ref31]^ reported no modification in quality of sleep or quality of life at the end of the proposed protocol. [Figure 2](#fig002){ref-type="fig"} shows a comparison of MIP values between Aslan^[@ref31]^ and Jevnikar.^[@ref29]^

Aerobic exercise and general physical activity {#sec2-3}
----------------------------------------------

Only one article addressed protocols for general physical exercise in patients with PD.^[@ref32]^ The study, already presented previously at the sixth European innovation summit on PD,^[@ref33]^ was conducted on a population of 25 patients with LOPD (23 completed the study), all of whom were undergoing ERT. The rehabilitation program, which lasted 12 weeks, included 36 sessions of aerobic training using a cycle ergometer, active resistance exercises (weights/mat activities), and core stability training. The authors evaluated the following as outcome measures: fatigue (using the Fatigue Severity Scale, FSS), plasma values of creatine kinase (CK; every two weeks), oxygen consumption during exercise (maximal oxygen uptake peak − VO^[@ref2]^ peak − and maximum work capacity − WMAX), maximum ventilatory threshold (VT), tolerance to exertion (using the Borg scale and six minute test), duration of hold in core stability exercises, muscular function (using the quick motor function test), and body composition (using dual X-ray absorptiometry, DXA). The authors report statistically significant increases in muscular endurance indices (VO~2~ peak, WMAX, and VT), an increase in the duration of hold in core stability exercises, and the muscular strength of some groups (hip flexors, shoulder abductors). All the other outcomes evaluated were stable.

Discussion {#sec1-4}
==========

The present review complies with the standards defined by the PRISMA statement for methodological quality of a literature review.^[@ref34]^ From what was illustrated above, rehabilitation in the management of patients with PD is a useful tool to strengthen the effects of ERT, contributing to the patient's greater respiratory and muscular compliance. In fact, in all studies examined, the two treatments were made simultaneously. ^[@ref29]^ However, this topic has been undervalued by the scientific literature. Indeed, from our review, no RCT or cohort studies with controlled groups were found. The studies that were found were only experiments with single cohorts, with a very small sample (8-9 subjects for the respiratory rehabilitation studies, 23 in the only motor re-education study). This obviously represents the main limitation and source of bias of the present review, and in general, of studies on rehabilitation in patients with rare neuromuscular pathologies.^[@ref35]^ With regard to indications deriving from our review, rehabilitation methods aimed at reinforcing the respiratory muscles seem to increase MIP levels with a statistically significant difference,^[@ref29],[@ref31]^ while only one publication^[@ref30]^ deviates from this trend. It should be mentioned that the study in question regarded a notably different population of patients with respect to both age of onset (IOPD) and ventilatory impairment (5 patients already depended on mechanical ventilation for most of the day). The main changes observed in this case were reported in the follow-up at 180 days (increase in flows and volumes of inspiratory rehabilitation after training). No other substantial changes were described with respect to the respiratory profile of the participants. The validity of inspiratory training with a threshold with level III evidence, represents the greatest innovation in our study. The guidelines currently drafted for PD advise other therapeutic measures (management of bronchial secretions via drainage techniques, assistance coughing with an inexsufflator, continuous monitoring of sleep problems with the C-pap machine).^[@ref27],[@ref40]^ However, the need remains for new RCTs with definitive EBM confirmation of these pulmonary rehabilitation protocols. Finally, with regard to the effectiveness of rehabilitative treatment based on aerobic and resistance training, the data uncovered refer only to a study by van Der Berg *et al*.^[@ref33]^ The trend of the sample studied shows a positive effect on the strength and endurance of some muscle groups, as well as on strength parameters of the core stability muscles. This seems to be confirmed in part by previous literature. Indeed, Kishnani *et al*.^[@ref40]^ advise starting patients on mainly aerobic rehabilitative activities immediately after the general medical conditions are stabilized, avoiding activities that excessively stimulate the weakened muscle groups in eccentric contractions. About this topic as well, however, it is necessary to make a deeper scientific investigation by carrying out studies with greater evidence (RCTs) and a larger sample.

Conclusions {#sec1-5}
===========

The present systematic literature review highlights that no sufficient studies on the methodological level exist today to support rehabilitation in the management of patients with PD. The cohort studies that are available suggest the use of inspiratory muscle training with a threshold to increase average MIP values (level III evidence) and rehabilitation programs based on physical aerobic exercise. However, new, broader studies are needed to definitively validate the abovementioned recommendations.
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###### 

Evaluation and rehabilitation of PD according to the recommendations by Clinton *et al.*^[@ref27]^

  Clinical recommendations
  --------------------------------------------------------------------------------------------------------------------------------------
  Preliminary assessment with a pulmonologist or cardiologist before performing aerobic exercises or physiotherapy
  Evaluate 6MWT at time 0
  Include in rehabilitation programs walking, treadmill, use of the cyclette, the hydrokinetic therapy, swimming, muscle strengthening
  Avoid excessively tiring exercises; avoid immobility
  Give emphasis to aerobic exercises
  Instruct the patient to monitor heart rate and breathing during exercise
  Use preventive braces for contractures while the patient is in a wheelchair, and adequate supports when standing
  Evaluate corrective surgery for scoliosis above 30-40°

###### 

Keyword used for the search.

  Keyword 1                         Keyword 2        Boolean operator
  --------------------------------- ---------------- ------------------
  Pompe Disease                     Physiotherapy    AND/OR
  Pompe Disease                     Rehabilitation   AND/OR
  Pompe Disease                     Management       AND/OR
  Glycogen Storage Disease Type 2   Physiotherapy    AND/OR
  Glycogen Storage Disease Type 2   Rehabilitation   AND/OR
  Glycogen Storage Disease Type 2   Management       AND/OR

###### 

Summary of included studies.

  Study                          Design          Participants   Intervention                                                                                Outcome measures
  ------------------------------ --------------- -------------- ------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------
  Jevnikar *et al.*29 2015       Single Cohort   n = 8          Exp = ERT +respiratory 45 min/day × 24 months                                               • MIP, MEP muscle training with threshold
                                                                                                                                                            • Follow up: 0,3,6,9,12,24 month
  Smith *et al.*30 2017          Single Cohort   n = 9          Exp = ERT + respiratory muscle training with PEEP 6/10 active breaths × 4 /day × 3 months   • Inspired tidal volume (VT), peak inspiratory flow (PIF), inspiratory pressure (PI), inspiratory time (TI), expiratory time (TE)
                                                                                                                                                            • Borg scale
                                                                                                                                                            • MIP
                                                                                                                                                            • Volume, flow and timing compensatory responses to inspiratory loads were evaluated using Threshold training devices
                                                                                                                                                            • EMG
                                                                                                                                                            • Follow up =0, 90, 180, 365 day
  Aslan *et al.*31 2016          Single Cohort   n = 9          Exp = ERT + respiratory muscle training with threshold 15 min × 2 /day × 8 wk               • MIP, Cough peak flow(PCF)
                                                                                                                                                            • Forced vital capacity (FVC), FVC/FEV1
                                                                                                                                                            • HRQoL (Nottingham Health Profile)
                                                                                                                                                            • Sleep quality (Pittsburgh Sleep Quality Index -PSQI).
                                                                                                                                                            • Follow up = 0, 8,16, 24 wk
  Van der Berg *et al.*32 2015   Single Cohort   n = 23         Exp = standardized aerobic, resistance and core stability exercises 3 /wk × 12 wk           • Fatigue severity scale
                                                                                                                                                            • Serum CK
                                                                                                                                                            • VO2 max and WMAX)
                                                                                                                                                            • Ventilator threshold (VT),
                                                                                                                                                            • Borg scale and 6MWT
                                                                                                                                                            • Resistance during core stability exercises,
                                                                                                                                                            • Quick motor function test
                                                                                                                                                            • DXA
                                                                                                                                                            • Follow up = 0, 12, 24 wk
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